As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...
Irish Examiner on MSN2d
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predictMedical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Antibiotic use was not associated with an increased risk of cognitive impairment and dementia in healthy older adults, ...
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
Louisville Public Media on MSN9h
New Indiana dementia outreach specialists connect with people in their communitiesAll 16 of Indiana’s designated senior care organizations are now required to have a dementia outreach specialist. The goal is ...
Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
The third most common form of dementia is often mistaken for Alzheimer's despite different treatment needsCognitive profiles ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback